Javascript must be enabled to continue!
Sustainability of Medtronic Surgical Devices
View through CrossRef
Background
Medical devices used in surgery have the potential to impact the environment. While it is essential for medical devices to be accessible, of quality design & manufacture, and cost effective, they must also aim at inducing the lowest environmental impact. Industry partners have a role in advising on end-of-life pathways and designing devices that lessen their impact on the environment.
Methods
Medtronic has multiple initiatives underway to reduce the environmental impact of its devices from design pathways to commercial programs. We summarize a few of the key surgical programs.
Results
Surgical staplers and energy devices are critical in many commonly performed surgeries. Medtronic’s Signia™ powered stapler has a reusable battery and can be used for 300 procedures, whereas the competitor’s powered stapler is used for one procedure. Similarly, Medtronic developed stapler reloads such as Tri-Staple™ reinforced reload with pre-loaded buttress material that not only reduces the clinical workflow demands but also reduces packaging waste compared to competitor buttress products that are sold separately. Medtronic’s Sonicision™ 7 cordless ultrasonic dissection device features a reusable generator and battery pack, whereas the competitors’ is single use with a large, bulky generator. Medtronic offers a LigaSure™ vessel sealing device collections program to ensure appropriate end-of-life pathway for the device.
Conclusion
Medtronic is playing a critical role in reducing the environmental impact of its devices while meeting customers’ needs and quality expectations.
Title: Sustainability of Medtronic Surgical Devices
Description:
Background
Medical devices used in surgery have the potential to impact the environment.
While it is essential for medical devices to be accessible, of quality design & manufacture, and cost effective, they must also aim at inducing the lowest environmental impact.
Industry partners have a role in advising on end-of-life pathways and designing devices that lessen their impact on the environment.
Methods
Medtronic has multiple initiatives underway to reduce the environmental impact of its devices from design pathways to commercial programs.
We summarize a few of the key surgical programs.
Results
Surgical staplers and energy devices are critical in many commonly performed surgeries.
Medtronic’s Signia™ powered stapler has a reusable battery and can be used for 300 procedures, whereas the competitor’s powered stapler is used for one procedure.
Similarly, Medtronic developed stapler reloads such as Tri-Staple™ reinforced reload with pre-loaded buttress material that not only reduces the clinical workflow demands but also reduces packaging waste compared to competitor buttress products that are sold separately.
Medtronic’s Sonicision™ 7 cordless ultrasonic dissection device features a reusable generator and battery pack, whereas the competitors’ is single use with a large, bulky generator.
Medtronic offers a LigaSure™ vessel sealing device collections program to ensure appropriate end-of-life pathway for the device.
Conclusion
Medtronic is playing a critical role in reducing the environmental impact of its devices while meeting customers’ needs and quality expectations.
.
Related Results
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct
Introduction
Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Medtronic, Inc. (A): The Garage Era
Medtronic, Inc. (A): The Garage Era
Useful in courses on entrepreneurship, this case describes the founding and start-up years (1949–62) of Medtronic, Inc., one of the world's leading medical-technology companies, sp...
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
105-LB: Glucose Variability with Second-Generation Basal Insulin Analogs Glargine 300 U/mL and Degludec 100 U/mL, Evaluated by CGM in People with T1D—The InRange Randomized Controlled Trial
Background: InRange has previously demonstrated that insulin glargine 300 U/mL (Gla-300) is non-inferior to insulin degludec 100 U/mL (IDeg-100) in terms of time in glucose range 7...
correlation of human capital sustainability leadership style and resilience of the managers in airline operations group of an AIRLINE Company
correlation of human capital sustainability leadership style and resilience of the managers in airline operations group of an AIRLINE Company
This study aimed to analyze the correlation between Human Capital Sustainability Leadership style and manager resilience through a pragmatic worldview. Using explanatory sequential...
Global Surgery Research: An Overview and the Role of Medical Students and Surgical Trainees in Advancing Global Surgery Research in LMICs
Global Surgery Research: An Overview and the Role of Medical Students and Surgical Trainees in Advancing Global Surgery Research in LMICs
Global surgery research is a critical area of study aimed at enhancing access to safe and effective surgical care for patients in low- and middle-income countries (LMICs). It is es...
Green Leadership as a Driver of Sustainability Transformation: Innovative Strategies Toward Organizational Sustainability in the Modern Era
Green Leadership as a Driver of Sustainability Transformation: Innovative Strategies Toward Organizational Sustainability in the Modern Era
Research Aims: This study aims to explore and analyze the impact of green leadership, sustainability strategies, modern organizations, and sustainability transformation on organiza...
277-OR: AID-Driven TIR Improvements in Young MDI Children with T1D Are Indistinguishable from Their Pump-Using Peers—A PEDAP Subanalysis
277-OR: AID-Driven TIR Improvements in Young MDI Children with T1D Are Indistinguishable from Their Pump-Using Peers—A PEDAP Subanalysis
Treatment of T1D in young children presents many challenges compared to other age groups. In a recent multicenter, randomized controlled trial, we showed significant glycemic impro...
928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)
928-P: AI-Based Fully Closed Loop (FCL) Achieves Improved Glycemia vs. Hybrid Closed Loop (HCL) in People with Type 1 Diabetes (T1D)
Introduction and Objective: HCL is the preferred insulin delivery method for people with T1D, however mealtime carbohydrate counting limits benefit. Use of AI to implement automate...

